NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020
Press Release
Read More
Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma
Literature
Read More
Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types
Literature
Read More
NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic
Press Release
Read More